Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1995 Apr;40(4):228-34.
doi: 10.1007/BF01519896.

Inhibitory effects of tamoxifen and tumor necrosis factor alpha on human glioblastoma cells

K Iwasaki  1 , S A Toms, G H Barnett, M L Estes, M K Gupta, B P Barna
Affiliations
Comparative Study

Inhibitory effects of tamoxifen and tumor necrosis factor alpha on human glioblastoma cells

K Iwasaki et al. Cancer Immunol Immunother. 1995 Apr.

Abstract

We reported previously that tumor necrosis factor alpha (TNF alpha) inhibited proliferation and invasiveness of human malignant glial cells. Because tamoxifen, an estrogen antagonist, has also been shown to inhibit growth of such cells, we hypothesized that a combination of tamoxifen and TNF alpha might be more effective than either reagent alone. TNF alpha (1-100 ng/ml) or tamoxifen (80 ng/ml-2 micrograms/ml) alone inhibited proliferation of a human glioblastoma cell line (WITG3) in a dose-dependent fashion; in combination, tamoxifen and TNF alpha yielded additive growth inhibition. Apoptotic cells characterized by nuclear fragmentation were detectable after 48 h of TNF alpha or tamoxifen exposure and were significantly increased by combination treatment. In non-neoplastic human astroglia and fibroblasts, proliferation was unaffected by tamoxifen, and enhanced by TNF alpha as previously reported. Staurosporine (2-50 nM), which has been reported to augment the effects of TNF alpha, was less effective than tamoxifen against WITG3 and, in addition, was markedly inhibitory to non-neoplastic glial cells. Binding studies yielded no evidence of WITG3 estrogen or progesterone receptors, nor of tamoxifen effects on TNF alpha receptors. Data suggest that TNF alpha and tamoxifen in combination display growth-regulatory properties, which (a) are more inhibitory to human glioblastoma cells than either agent alone, (b) do not affect non-neoplastic glia, (c) do not require either estrogen/progesterone receptors or alteration of external TNF alpha receptors, and (d) may involve apoptosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Aggarwal BB, Eessalu TE, Hass PE. Characterization of receptors for human tumor necrosis factor and their regulation by ψ-interferon. Nature. 1985;318:665–667. - PubMed
    1. Barna BP, Estes ML, Jacobs BS, Hudson S, Ransohoff RM. Human astrocytes proliferate in response to tumor necrosis factor alpha. J Neuroimmunol. 1990;30:239–243. - PubMed
    1. Barna BP, Barnett GH, Jacobs BS, Estes ML. Divergent responses of human astrocytoma and non-neoplastic astrocytes to tumor necrosis factor alpha involve the 55 kDa tumor necrosis factor receptor. J Neuroimmunol. 1993;431:185–190. - PubMed
    1. Benzil DL, Finkelstein SD, Epstein MH, Finch PW. Expression pattern of α-protein kinase C in human astrocytomas indicates a role in malignant progression. Cancer Res. 1992;52:2951–2956. - PubMed
    1. Beutler B, Cerami A. The biology of cachectin/TNF — a primary mediator of the host response. Annu Rev Immunol. 1989;7:625–655. - PubMed

Publication types

MeSH terms

LinkOut - more resources